NCT06190340View on ClinicalTrials.gov

A Phase 1 Study to Evaluate PK Profile of Multiple Oral Administrations of TNP-2092 Capsules in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 8, 2016

Primary Completion Date

September 26, 2017

Study Completion Date

September 26, 2017

Conditions

Helicobacter Pylori Infection

Interventions

DRUG

TNP-2092 capsules

Administration orally.

DRUG

Placebo

Administration orally.

Trial Locations (1)

Unknown

The First Hospital of Jilin University, Changchun

All Listed Sponsors

collaborator

The First Hospital of Jilin University

OTHER

lead

TenNor Therapeutics (Suzhou) Limited

INDUSTRY

NCT06190340 - A Phase 1 Study to Evaluate PK Profile of Multiple Oral Administrations of TNP-2092 Capsules in Healthy Subjects | Biotech Hunter | Biotech Hunter